Announcement
25 Apr 2024
In April 2024, NIB announced a ten-year financing agreement where the institution granted EUR 22.5 million to UAB Celltechna for a gene therapy product facility in Vilnius, Lithuania.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
25 Apr 2024
Revocation date:
No revocation date
Updated: 25 Apr 2024
State loan
In force
On 25 April 2024, the Nordic Investment Bank (NIB) provided EUR 22.5 million (approx. 24.4 million) through a ten-year financing agreement to the Lithuanian biopharmaceutical company UAB Celltechna...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.